CLOZAPINE FOR THE TREATMENT-RESISTANT SCHIZOPHRENIC - RESULTS OF A UNITED-STATES MULTICENTER TRIAL

被引：38

作者：

KANE, JM

HONIGFELD, G

SINGER, J

MELTZER, H

机构：

[1] SANDOZ RES INST,E HANOVER,NJ 07936

[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PSYCHIAT,BRONX,NY 10461

[3] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,PISCATAWAY,NJ 08854

[4] CASE WESTERN RESERVE UNIV,SCH MED,DEPT PSYCHIAT,CLEVELAND,OH 44106

来源：

PSYCHOPHARMACOLOGY | 1989年 / 99卷

关键词：

D O I：

10.1007/BF00442561

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：S60 / S63

页数：4

共 9 条

[1]

CLAGHORN J, 1987, J CLIN PSYCHOPHARM, V7, P377

[2] DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].

CREESE, I ;

BURT, DR ;

SNYDER, SH .

SCIENCE, 1976, 192 (4238) :481-483

[3] IMPORTANT ISSUES IN THE DRUG-TREATMENT OF SCHIZOPHRENIA [J].

DAVIS, JM ;

SCHAFFER, CB ;

KILLIAN, GA ;

KINARD, C ;

CHAN, C .

SCHIZOPHRENIA BULLETIN, 1980, 6 (01) :70-87

[4]

FISCHER-CORNELSSEN K A, 1976, Psychopharmacology Bulletin, V12, P34

[5]

GRIFFITH RW, 1975, LANCET, V2, P657

[6] CLOZAPINE - PLASMA-LEVELS AND PROLACTIN RESPONSE [J].

KANE, JM ;

COOPER, TB ;

SACHAR, EJ ;

HALPERN, FS ;

BAILINE, S .

PSYCHOPHARMACOLOGY, 1981, 73 (02) :184-187

[7]

Klein D. F., 1969, DIAGNOSIS DRUG TREAT

[8]

MELTZER HY, 1979, AM J PSYCHIAT, V136, P1550

[9] CONTROVERSY IN COUNTING AND ATTRIBUTING EVENTS IN CLINICAL-TRIALS [J].

SACKETT, DL ;

GENT, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (26) :1410-1412

← 1 →